Summary
The Molbio Diagnostics IPO has been subscribed 17.37 times by Day 3, with a grey market premium (GMP) of ₹138 per share, indicating strong investor interest.
Molbio Diagnostics IPO Subscribed 17.37 Times on Day 3, GMP at ₹138
HyperFast News
Select what you want to create
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.
Image Post
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostPrompt to Post
Describe the story, headline, colors, and style you want.
Try Prompt to PostAudio Post
Combine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostVideo Post
Upload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostMulti-News Carousel
Combine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload and Schedule
Upload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostBlog Post
Transform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostComing soon
AI Anchor Video
Turn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreFAQ
Newsroom FAQs
About the public HyperFast News news feed powered by NewsEngine.